Literature DB >> 6343373

Regulation of the synthesis and degradation of pyruvate carboxylase in 3T3-L1 cells.

S O Freytag, M F Utter.   

Abstract

The differentiation of mouse 3T3-L1 cells is characterized by an accumulation of cytosolic triglyceride and marked increase in many enzymatic activities involved in triglyceride biosynthesis. The specific activity of one such enzyme, pyruvate carboxylase, increases at least 20-fold and is due to a parallel increase in the intracellular concentration of the protein. Pulse-labeling experiments demonstrated that the increase in the specific activity of pyruvate carboxylase was due to an increase in the rate of enzyme synthesis. In the differentiated cell, pyruvate carboxylase represented 1.9% of the total cellular protein and 1% of the protein radiolabeled during a 1-h pulse. This was 35-and 28-fold higher than in the undifferentiated cell, respectively. The turnover of pyruvate carboxylase in the differentiated cell was similar to that in the undifferentiated cell with the enzyme having a half-life of 28-35 h. The half-life of apopyruvate carboxylase in avidin-treated 3T3-L1 cells was 24 h, indicating that the turnover of the apoenzyme was not significantly different than that of the holoenzyme. Radiolabeling pyruvate carboxylase with [14C]biotin and [3H]leucine demonstrated that the turnover of biotin associated with the enzyme was identical to the turnover of the enzymatic protein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343373

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Structure, function and regulation of pyruvate carboxylase.

Authors:  S Jitrapakdee; J C Wallace
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Biotinidase deficiency: a novel vitamin recycling defect.

Authors:  B Wolf; R E Grier; J R Secor McVoy; G S Heard
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

3.  Distribution and degradation of biotin-containing carboxylases in human cell lines.

Authors:  C S Chandler; F J Ballard
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

4.  Biotin uptake into human peripheral blood mononuclear cells increases early in the cell cycle, increasing carboxylase activities.

Authors:  J Steven Stanley; Donald M Mock; Jacob B Griffin; Janos Zempleni
Journal:  J Nutr       Date:  2002-07       Impact factor: 4.798

5.  K12-biotinylated histone H4 is enriched in telomeric repeats from human lung IMR-90 fibroblasts.

Authors:  Subhashinee S K Wijeratne; Gabriela Camporeale; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2009-04-14       Impact factor: 6.048

6.  1α,25-dihydroxyvitamin D inhibits de novo fatty acid synthesis and lipid accumulation in metastatic breast cancer cells through down-regulation of pyruvate carboxylase.

Authors:  Tomasz Wilmanski; Kimberly Buhman; Shawn S Donkin; John R Burgess; Dorothy Teegarden
Journal:  J Nutr Biochem       Date:  2016-12-01       Impact factor: 6.048

7.  Characterisation of G418-induced metabolic load in recombinant CHO and BHK cells: effect on the activity and expression of central metabolic enzymes.

Authors:  C A Yallop; P L Nørby; R Jensen; H Reinbach; I Svendsen
Journal:  Cytotechnology       Date:  2003-07       Impact factor: 2.058

8.  Biotin and biotinidase deficiency.

Authors:  Janos Zempleni; Yousef I Hassan; Subhashinee Sk Wijeratne
Journal:  Expert Rev Endocrinol Metab       Date:  2008-11-01

9.  The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro.

Authors:  Sarawut Jitrapakdee; Marc Slawik; Gema Medina-Gomez; Mark Campbell; John C Wallace; Jaswinder K Sethi; Stephen O'rahilly; Antonio J Vidal-Puig
Journal:  J Biol Chem       Date:  2005-05-25       Impact factor: 5.157

10.  Holocarboxylase synthetase knockout is embryonic lethal in mice.

Authors:  Mahrou Sadri; Haichuan Wang; Toshinobu Kuroishi; Yong Li; Janos Zempleni
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.